InsiderSource
MIST

Milestone Pharmaceuticals Inc.

SEC CIK 1408443
$1.27 −32.1% · 90 days
90-day buys
$0
0 open-market
90-day sells
$82.5K
1 open-market
Net insider flow
−$82.5K
Net selling
Filings shown
31
Most recent
Advertisement

At a glance

Over the last 90 days, insiders at MIST have sold a net $82.5K of stock (0 open-market buys vs 1 sell).

Largest recent trade: Oliveto Joseph sold $308.7K of MIST, trimming their stake 23%.

Most active filer: Oliveto Joseph, with 8 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for MIST, newest first
View on SEC EDGAR ↗
MIST
Milestone Pharmaceuticals Inc.
Sell Oliveto Joseph · Director, President and CEO · Open-market sale · filed Apr 20, 2026 ΔOwn −7.6%

Oliveto Joseph sold $82.5K of MIST, trimming their stake 8%.

−$82.5K
36,500 sh @ $2
MIST
Milestone Pharmaceuticals Inc.
Sell Bharucha David · Chief Medical Officer · Open-market sale · filed Jan 28, 2026 ΔOwn −9.8%

Bharucha David sold $23.6K of MIST, trimming their stake 10%.

−$23.6K
12,245 sh @ $2
Advertisement
MIST
Milestone Pharmaceuticals Inc.
Sell Muller Lorenz · Chief Commercial Officer · Open-market sale · filed Jan 28, 2026 ΔOwn −5.2%

Muller Lorenz sold $21.6K of MIST, trimming their stake 5%.

−$21.6K
11,180 sh @ $2
MIST
Milestone Pharmaceuticals Inc.
Sell Hasija Amit · CFO & EVP of Corp. Development · Open-market sale · filed Jan 28, 2026 ΔOwn −11%

Hasija Amit sold $23.6K of MIST, trimming their stake 11%.

−$23.6K
12,245 sh @ $2
MIST
Milestone Pharmaceuticals Inc.
Sell Oliveto Joseph · Director, President and CEO · Open-market sale · filed Jan 28, 2026 ΔOwn −6.7%

Oliveto Joseph sold $66.6K of MIST, trimming their stake 7%.

−$66.6K
34,523 sh @ $2
MIST
Milestone Pharmaceuticals Inc.
Sell Oliveto Joseph · Director, President and CEO · Open-market sale · filed Jan 9, 2026 ΔOwn −12%

Oliveto Joseph sold $96.8K of MIST, trimming their stake 12%.

−$96.8K
43,000 sh @ $2
MIST
Milestone Pharmaceuticals Inc.
Sell Bharucha David · Chief Medical Officer · Open-market sale · filed Jan 28, 2026 ΔOwn −36%

Bharucha David sold $134.6K of MIST, trimming their stake 36%.

−$134.6K
58,007 sh @ $2
MIST
Milestone Pharmaceuticals Inc.
Sell Muller Lorenz · Chief Commercial Officer · Open-market sale · filed Jan 28, 2026 ΔOwn −21%

Muller Lorenz sold $124.3K of MIST, trimming their stake 21%.

−$124.3K
53,566 sh @ $2
MIST
Milestone Pharmaceuticals Inc.
Sell Hasija Amit · CFO & EVP of Corp. Development · Open-market sale · filed Jan 28, 2026 ΔOwn −39%

Hasija Amit sold $134.6K of MIST, trimming their stake 39%.

−$134.6K
58,007 sh @ $2
MIST
Milestone Pharmaceuticals Inc.
Sell Oliveto Joseph · Director, President and CEO · Open-market sale · filed Jan 28, 2026 ΔOwn −23%

Oliveto Joseph sold $308.7K of MIST, trimming their stake 23%.

−$308.7K
133,054 sh @ $2
Advertisement

About MIST insider activity

This page tracks every recent Form 4 filed for Milestone Pharmaceuticals Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is MIST insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for Milestone Pharmaceuticals Inc. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.